Keywords: ks, biomedix, begins, ph, ii, cb-2431, trial

KS Biomedix Begins Ph II CB-2431 Trial

Article | 24 July 1997

Print This

- New UK-based biotechnology company KS Biomedix has started a Phase IItrial of CB-2431, an oral combination product for osteoarthritis. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in